Delivery Order SPE2DB22D2007-SPE2DB25FJ1FW

Award Date 5/6/25
Potential Completion Date 5/28/25
Potential Value $15K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $11,471.10, is for the provision of OPDIVO 240 MG/24 ML VIAL 24ML, a pharmaceutical product. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a prescription medication. The contract has a ceiling value of $59,627.16 and a performance period through May 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a pharmaceutical product, with a ceiling value of $61,029.25. The contract is a firm fixed-price, non-set-aside delivery order with a period of performance through May 27, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Opdivo 240 mg/24 ml vials, a prescription medication. The contract has a firm fixed price of $9,937.86 and a performance period ending on May 28, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds...
This is a $78,951.60 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty cancer medication. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,371.90, is for the procurement of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product. The contract has an ultimate completion date of January 12, 2024 and is a firm fixed-price delivery order. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,937.86, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product. The contract has a period of performance through February 11, 2025 and utilizes a firm fixed-price pricing structure. This award is associated with a larger Indefinite Delivery Contract (IDC)...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The contract is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a prescription medication, at a fixed price of $38,237.00. The ultimate completion date for this delivery order is September 24, 2024. This contract is not a set-aside and is part of a larger Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPDIVO 100 MG/10 ML VIAL 10ML, a pharmaceutical product, with a ceiling value of $12,386.52 and a performance period through June 2, 2025. The contract is a firm fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OPDIVO 240 MG/24 ML VIAL 24ML, a specialty pharmaceutical product, with a ceiling value of $19,875.72 and a performance period through March 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
  • SPE2DB22D2007
    Indefinite Delivery Contract
  • SPE2DB22D2007-SPE2DB25FJ1FW
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,906.79, is for the supply of OPDIVO 240 MG/24 ML VIAL 24ML, a prescription medication. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract is not set aside and is open to full and open competition. The contract will support medical procurement needs, particularly for military and veteran healthcare systems, by enabling the delivery of a wide range of pharmaceutical products and medical supplies.

Generated 8/10/25, 12:47 AM